BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright ©The Author(s) 2026.
World J Cardiol. Jan 26, 2026; 18(1): 111736
Published online Jan 26, 2026. doi: 10.4330/wjc.v18.i1.111736
Table 1 Demographic characteristics, comorbidities, atherosclerotic disease, and chronic therapy, n (%)
Variable
Occluded artery (n = 1687, 67.9%)
Patent artery (n = 796, 32.1%)
P value
Age (years)63 (55-73)66.3 (58-75)< 0.0001
Male sex1206 (72.9)572 (71.87)0.584
Comorbidities
Atrial fibrillation95 (5.7)65 (8.2)0.018
Arterial hypertension1176 (71.1)624 (78.4)< 0.0001
Diabetes mellitus346 (20.9)236 (29.6)< 0.0001
Family history of CV diseases545 (33.0)280 (35.2)0.649
Smoking676 (40.6)278 (34.9)< 0.001
BMI (kg/m2)27.8 (25.3-30.9)27.8 (25.0-30.5)0.388
Extent of atherosclerotic disease
Carotid stenosis60 (3.6)54 (6.8)< 0.0001
Peripheral artery disease89 (5.4)66 (8.3)< 0.005
Previous CABG26 (1.6)14 (1.8)0.735
Previous PCI140 (8.5)89 (11.2)0.030
Previous MI166 (10.0)117 (14.7)< 0.0001
Previous stroke83 (5.0)46 (5.8)0.427
Chronic therapy (> 4 weeks before AMI)
ASA269 (16.3)178 (22.4)< 0.0001
ACEi/ARB618 (37.4)335 (22.1)0.005
Beta-blockers372 (22.5)225 (28.3)< 0.0001
Statins255 (15.4)174 (21.9)< 0.0001
Table 2 Clinical presentation, laboratory values, Global Registry of Acute Coronary Events score, and percutaneous coronary intervention findings, n (%)
Variable
Occluded artery (n = 1687, 67.9%)
Patent artery (n = 796, 32.1%)
P value
STEMI1350 (81.6)184 (23.1)< 0.0001
VT before/during PCI48 (2.9)17 (2.1)0.278
Systolic BP on admission (mmHg)130 (115-150)140 (120-155)< 0.0001
Cardiogenic shock107 (6.5)19 (2.49)< 0.0001
Out-of-hospital arrest62 (3.7)12 (1.5)0.003
GRACE score141.5 (96-175)144 (75-106)0.300
Laboratory values
Hemoglobin (g/L)143 (131-153)141 (129-150)0.003
eGFR (mL/minutes/1.73 m2)73 (59-88)73 (58-87)0.539
LDL cholesterol (mmol/L)3.5 (2.7-4.2)3.1 (2.3-3.9)< 0.0001
Creatine kinase - peak (U/L)1629 (716-3406)354 (163-812)< 0.0001
Troponin I - peak (ng/L)20315 (16289-22154)55000 (1461-3525)< 0.0001
PCI-related findings
SYNTAX score21 (17-26)23 (18-27)< 0.0001
TIMI 3 as the final angiogram1284 (77.6)685 (86.1)< 0.0001
Stenosis of the LMCA60 (3.6)80 (29.3)< 0.0001
Table 3 Predictors of infarct-related artery occlusion (χ2 = 93.053; df = 8; P < 0.0001)
Covariate
P value
Odd ratio
95%CI
Age0.00230.97220.9547-0.9900
Sex (female)0.27561.33010.7965-2.2212
Troponin I (max value)< 0.00011.00001.0000-1.0001
Peripheral artery disease0.87780.94000.4271-2.0688
Diabetes mellitus0.13620.69680.4333-1.1206
Body mass index0.37991.02120.9744-1.0703
eGFR0.07940.99180.9827-1.0010
Statin therapy before AMI0.01680.57680.3674-0.9057
Arterial hypertension0.31120.74150.6784-1.2154
Table 4 Cox proportional hazards regression for 30-day mortality (χ2 = 97.130; df = 14; P < 0.0001)
Covariate
P value
Hazard ratio
95%CI
Age< 0.00011.06261.0341-1.0919
Sex (female)0.09741.55270.9229-2.6123
ECG presentation (NSTEMI)0.89861.04040.5659-1.9128
Occluded culprit coronary artery0.00313.03671.4543-6.3411
Ventricular tachycardia before or during PCI0.00643.84581.4600-10.1299
Peripheral artery disease0.12271.81680.8513-3.8774
Statin therapy before myocardial infarction 0.33001.35230.7368-2.4820
BMI0.21161.03570.9802-1.0943
GRACE0.01881.00651.0011-1.0120
LDL - cholesterol0.27440.88940.7208-1.0974
SYNTAX0.80501.00500.9659-1.0458
Diabetes mellitus 0.21221.21210.5257-1.3124
Arterial hypertension0.98781.42450.7854-1.3154